Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 167

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models

Open access
Shenoy, Vinayak, Gjymishka, Altin, Jarajapu, Yagna P., Qi, Yanfei, Afzal, Aqeela, Rigatto, Katya, Ferreira, Anderson J., Fraga-Silva, Rodrigo A., Kearns, Patrick, Douglas, Jane Yellowlees, Agarwal, Deepmala, Mubarak, Kamal K., Bradford, Chastity, Kennedy, William R., Jun, Joo Y., Rathinasabapathy, Anandharajan, Bruce, Erin, Gupta, Dipankar, Cardounel, Arturo J., Mocco, J., Patel, Jawaharlal M., Francis, Joseph, Grant, Maria B., Katovich, Michael J., Raizada, Mohan K.·2013·American Journal of Respiratory and Critical Care Medicine

Abstract

RATIONALE: Studies have demonstrated that angiotensin-converting enzyme 2 (ACE2) plays a protective role against lung diseases, including pulmonary hypertension (PH). Recently, an antitrypanosomal drug, diminazene aceturate (DIZE), was shown to exert an "off-target" effect of enhancing the enzymatic activity of ACE2 in vitro. OBJECTIVES: To evaluate the pharmacological actions of DIZE in experimental models of PH. METHODS: PH was induced in male Sprague Dawley rats by monocrotaline, hypoxia, or bleomycin challenge. Subsets of animals were simultaneously treated with DIZE. In a separate set of experiments, DIZE was administered after 3 weeks of PH induction to determine whether the drug could reverse PH. MEASUREMENTS AND MAIN RESULTS: DIZE treatment significantly prevented the development of PH in all of the animal models studied. The protective effects were associated with an increase in the vasoprotective axis of the lung renin-angiotensin system, decreased inflammatory cytokines, improved pulmonary vasoreactivity, and enhanced cardiac function. These beneficial effects were abolished by C-16, an ACE2 inhibitor. Initiation of DIZE treatment after the induction of PH arrested disease progression. Endothelial dysfunction represents a hallmark of PH pathophysiology, and growing evidence suggests that bone marrow-derived angiogenic progenitor cells contribute to endothelial homeostasis. We observed that angiogenic progenitor cells derived from the bone marrow of monocrotaline-challenged rats were dysfunctional and were repaired by DIZE treatment. Likewise, angiogenic progenitor cells isolated from patients with PH exhibited diminished migratory capacity toward the key chemoattractant stromal-derived factor 1α, which was corrected by in vitro DIZE treatment. CONCLUSIONS: Our results identify a therapeutic potential of DIZE in PH therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201205-0880oc

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 167

Metadata

Authors
Shenoy, V., Gjymishka, A., Jarajapu, Y. P., Qi, Y., Afzal, A., Rigatto, K., Ferreira, A. J., Fraga-Silva, R. A., Kearns, P., Douglas, J. Y., Agarwal, D., Mubarak, K. K., Bradford, C., Kennedy, W. R., Jun, J. Y., Rathinasabapathy, A., Bruce, E., Gupta, D., Cardounel, A. J., Mocco, J., Patel, J. M., Francis, J., Grant, M. B., Katovich, M. J., & Raizada, M. K.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2013-03-15
Volume
187
Issue
6
Pages
648-657
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2008054951
Cited by
167
References
3
FWCI
10.23
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models. https://app.cochat.ai/papers/10.1164/rccm.201205-0880oc
The paper
Shenoy, V., Gjymishka, A., Jarajapu, Y. P., Qi, Y., Afzal, A., Rigatto, K., Ferreira, A. J., Fraga-Silva, R. A., Kearns, P., Douglas, J. Y., Agarwal, D., Mubarak, K. K., Bradford, C., Kennedy, W. R., Jun, J. Y., Rathinasabapathy, A., Bruce, E., Gupta, D., Cardounel, A. J., . . . Raizada, M. K. (2013). Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201205-0880oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.